Today: 20 May 2026
Browse Category

NASDAQ:SWRM 19 March 2026

Swarmer Stock Surges Again After IPO as Ukraine-Tested Drone Software Draws Wall Street

Swarmer Stock Surges Again After IPO as Ukraine-Tested Drone Software Draws Wall Street

Swarmer shares soared 77% to $55 on Wednesday, following a 520% surge from its $5 IPO price. The Austin-based drone software firm raised $14.7 million in its offering, but 2025 revenue fell to $309,920 and net loss widened to $8.5 million. Its software has supported over 100,000 combat missions in Ukraine. The company reported no material business with its main customer going forward.
19 March 2026
····

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

20 May 2026
e.l.f. Beauty forecast fiscal 2027 sales and adjusted profit below Wall Street estimates, citing $15–$20 million in potential oil-related costs from the Iran war. Fourth-quarter net sales rose 35% to $449.3 million, beating expectations, but the company posted a $49.4 million net loss due to a $57.6 million charge tied to the Rhode acquisition. Shares rose after hours despite closing down 4.3% earlier.
Go toTop